According to Data Bridge Market Research new Market report “Global Self-Injections Market, By Product (Devices (Needle-Free Injectors, Auto Injectors, Pen Injectors, Wearable Injectors), Formulations), Dosage Form (Single Dose, Multi-Dose), Therapeutic Application (Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Others), By Route Of Administration (Skin, Circulatory/Musculoskeletal, Organs, Central Nervous System), By End-User (Patient, Physicians, Home Care Settings, Others), By Distribution Channel (Hospital Pharmacies, Private Clinics, Chemist, Online Pharmacies), By Geography (North America, Europe, Asia-Pacific, Middle East And Africa, South America, Rest Of The World) - Trends and Forecast to 2022”, has accounted for USD 19.1 billion in 2015 and is expected to reach USD 79.5 billion by 2022, growing at a CAGR of 22.6% in the forecasted period 2016 to 2022.
The global self-injections market is expected to grow exponentially in the forecast period. The exponential growth is owing to multiple factors but the most prominent is development of biologic drugs for the treatment of autoimmune diseases. Due to the viscosity of biologic drugs the auto-injector is expected to serve as one of the best ways of drug delivery by self-injections. According to World Health Organization (WHO) there is over 5% of the global population suffering from autoimmune disease and the growing awareness among patients that new drugs being developed is expected to cure the disease in place of just suppressing the symptoms, the market will experience a rapid growth in the forecast years.
U.S. is striving to manage its healthcare costs and the realizations of self-injections may decrease the high costs of everyday in-patient and out-patient facilities. Also the exponential growth of prefilled syringes will drive the market for self-injections to grow in the forecast years. In 2015, in Europe alone there was more than 2.4 billion units of pre-filled syringes shipped, which serves as an indicator for the growing needs of self-injection devices in the global market.
Some of the major drugs in which self-injections will experience an exponential growth are anaphlyaxis, erythropoietin (EPO), somatotrophins and follicle stimulating hormonal (FSH) drugs. Some major indications where self-injection devices are expected to grow are rheumatological diseases, inflammatory bowel disease, autoimmune systemic therapy, transplant modulation, seronegative arthritides and vaccinations of which there will be innumerate possibilities.
Based on geography the market for global self-injections is segmented into geographical regions such as North America, Europe, Asia-Pacific, South America, Middle East and Africa and, Rest of the World. North America is the largest market while Asia-Pacific is the fastest growing market due to the increase in incidence of chronic diseases, increasing health awareness, improving healthcare systems, and available disposable income. The report of this market are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa.
The global self-injections market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. Some examples of recent strategies adopted by market players are: May 2014, Teva received the FDA approval for SYNRIBO (omacetaxine mepesuccinate) which is used in the treatment of adult patients in the chronic phase of chronic myeloid leukemia; In August 2016, Myalan is expected to launch the first generics for epipen auto injector at half the price. The report includes market shares of self-injections market for global, North America, Europe, Asia-Pacific, Middle East and Africa, South America, Rest of the World.
The global self-injections market report contains an in-depth profiling of the key market players, along with the recent developments (New product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market. Some of the major players operating in this market are Abbvie, Inc., Antares Pharma, 3M, Becton Dickinson & Company, Baxter International Inc., Penjet Corporation, PharmaJet, Gerresheimer AG, Pfizer Inc., Terumo Corporation, Mylan Specialty L.P., SHL Group, Bespak, Janssen Biotech, Inc., Insulet Corporation, Unilife Corporation, West Pharmaceutical Services, Inc., Ypsomed, among other companies.
Browse Related Reports:
Global Injectable Drug Delivery Market, By Type (Devices (Conventional Injection Devices, Self Injection Devices), Formulations (Conventional Drug Delivery, Noble Drug Delivery, Long Acting Injection Formulations), By Applications (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Oncology, Others), By Usage Pattern (Curative Care, Immunizations, Other Usage Patterns), By Mode of Administration (Skin, Circulatory, Organs, Central Nervous System), By End User (Hospitals, Clinics, Home Care Settings, Research Laboratories, Pharma & Biotech Companies), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) – Trends and Forecast to 2022
Global Cord Stem Cell Banking Market, By Storage Type (Private Banking, Public Banking), By Product Type (Cord Blood, Cord Blood & Cord Tissue), By Service Type (Collection & Transportation, Processing, Analysis, Storage), By Source (Umbilical Cord Blood, Bone Marrow, Peripheral Blood Stem, Menstrual Blood), By Indication (Cerebral Palsy, Thalassemia, Leukemia, Diabetes, Autism), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) – Trends and Forecast to 2022
4th Floor, Mega Center,
Magarpatta City, Pune – 411028
Visit Data Bridge Blog@ http://databridgemarketresearch.com/blog/
Global Self-Injections Market – Industry Trends - Forecast to 2026